Ehinger, Johannes K. http://orcid.org/0000-0002-2417-5767
Piel, Sarah
Ford, Rhonan
Karlsson, Michael
Sjövall, Fredrik
Frostner, Eleonor Åsander
Morota, Saori
Taylor, Robert W.
Turnbull, Doug M.
Cornell, Clive
Moss, Steven J.
Metzsch, Carsten
Hansson, Magnus J.
Fliri, Hans
Elmér, Eskil
Article History
Received: 16 April 2016
Accepted: 21 June 2016
First Online: 9 August 2016
Competing interests
: This study is partly funded by NeuroVive Pharmaceutical AB and Selcia Ltd, companies active in the field of mitochondrial medicine. J.K.E., S.M., E.E., M.J.H., M.K., S.P., F.S., S.J.M. and E.Å.F. have or have had salary from and/or equity interest in NeuroVive Pharmaceutical. H.F., R.F. and C.C. have or have had salary from and/or equity interest in Selcia Ltd/Mitopharm Ltd.